5'-adenylyl (beta,gamma-methylene)diphosphonate has been researched along with cyclohexanol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Craib, SJ; Pertwee, RG; Ross, RA; Thomas, A | 1 |
Mahadevan, A; Pertwee, RG; Razdan, RK; Ross, RA; Saha, B; Thomas, A | 1 |
2 other study(ies) available for 5'-adenylyl (beta,gamma-methylene)diphosphonate and cyclohexanol
Article | Year |
---|---|
(-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens.
Topics: Adenosine Triphosphate; Animals; Benzoxazines; Cannabidiol; Cyclohexanols; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; In Vitro Techniques; Male; Methoxamine; Mice; Morpholines; Muscle Contraction; Naphthalenes; Norepinephrine; Phenylephrine; Receptors, Cannabinoid; Receptors, Drug; Vas Deferens; Vasoconstrictor Agents | 2002 |
6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist.
Topics: Adenosine Triphosphate; Adrenergic alpha-Agonists; Animals; Binding, Competitive; Brain Chemistry; Cannabidiol; Cyclohexanols; Electric Stimulation; In Vitro Techniques; Male; Membranes; Mice; Phenylephrine; Receptor, Cannabinoid, CB1; Vas Deferens | 2004 |